Moreover, the higher expression of S100A1 [14], S100A4 [15], S100A9 [16], S100A10 [17], S100A14 [18], and S100P [19] has been shown to be associated with shorter survival among HCC patients. Here, S100P is linked to hepatocellular carcinoma.